Daylight
Digital program to reduce worry and anxiety
Software · Cloud SaaSCompany source
Company profile
About Limbix
Big Health is a digital therapeutics company that delivers evidence-based mental health treatments through fully digital platforms. The company has treated over 500,000 patients and offers both prescription digital therapeutics (SleepioRx for chronic insomnia and DaylightRx for generalized anxiety disorder) and direct-access solutions (Sleepio, Daylight, and Spark Direct) for workplace mental health. Big Health's solutions are built on cognitive behavioral therapy (CBT) principles and are backed by over 100 peer-reviewed publications and 22 completed randomized controlled trials. The company's products have achieved FDA clearance and are reimbursable treatments that can be prescribed by healthcare providers. Big Health serves three primary markets: health systems and providers seeking to address patient demand and waitlists with reimbursable treatments, health plans looking to scale access to first-line mental health care while reducing costs, and employers aiming to provide instant access to mental health solutions for employees and their families. The company's solutions demonstrate significant clinical outcomes, with patients showing 76% improvement in sleep, 71% improvement in worry and anxiety, and 67% improvement in mood. With a 4+ App Store rating and 9.8/10 client implementation satisfaction score, Big Health has established itself as a trusted provider of digital mental health care. The company's treatments are referenced in clinical guidelines including those from the American College of Physicians, validating their position as evidence-based first-line interventions for common mental health conditions.
Company description Limbix official website
Primary marketMental Health & Digital Therapeutics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Limbix?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Chronic insomnia disorder
- Depression/low mood
- Generalized anxiety disorder (GAD)
- Sleep quality issues
- Worry and anxiety symptoms
Who it serves
- Employers
- Health Plans
- Health Systems
- Healthcare Providers
- Payers
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsUnited Kingdom · United States
Company sourceOfficial website
Company milestones
Platform expansion
Treated 500,000+ patients. FDA clearance for SleepioRx and DaylightRx as prescription digital therapeutics.
Partnerships
Recorded partners
No partners are currently listed.
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
DaylightRx
FDA-cleared prescription digital therapeutic for generalized anxiety disorder
Software · Cloud SaaSCompany source
Sleepio
Evidence-based digital program to improve sleep quality
Software · Cloud SaaSCompany source
SleepioRx
FDA-cleared prescription digital therapeutic for chronic insomnia
Software · Cloud SaaSCompany source
Spark Direct
Digital program to improve mood and mental well-being
Software · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Feasibility, acceptability, patient experience, and preliminary efficacy of a virtual reality guided imagery intervention for chronic pain.Frontiers in digital health · Jan 1, 2025
Hub disruption in HIV disease and cocaine use: A connectomics analysis of brain function.Drug and alcohol dependence · Oct 1, 2024
Cocaine Use Prediction With Tensor-Based Machine Learning on Multimodal MRI Connectome Data.Neural computation · Dec 12, 2023
A CBT-based mobile intervention as an adjunct treatment for adolescents with symptoms of depression: a virtual randomized controlled feasibility trial.Frontiers in digital health · Jan 1, 2023
Age-related change in task-evoked amygdala-prefrontal circuitry: A multiverse approach with an accelerated longitudinal cohort aged 4-22 years.Human brain mapping · Jul 1, 2022
Meaningful engagement: A crossfunctional framework for digital therapeutics.Frontiers in digital health · Jan 1, 2022
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
76% improvement in sleep
Demonstrated across multiple studies including RCTs in adults and older adults (65+)
71% improvement in worry and anxiety
RCT for moderate-to-severe generalized anxiety disorder symptoms
67% improvement in mood
25% improvement in validated screening measure scores (unpublished RCT, Dec 2023)
9.8/10 client implementation satisfaction score
Customer satisfaction metric
4+ App Store rating
User satisfaction
Desiree
Managing overwhelming life challenges and mental health
Improved mental health awareness and learned different reaction strategies
Jason
Improving mental health awareness and emotional regulation for high school student
Increased self-awareness and feelings of joy
Josh
Managing anxiety as a caregiver
Acquired useful coping mechanisms for ongoing anxiety management
Julia
Managing anxiety as a recent graduate in a new city
Increased sense of control over anxiety through learned techniques
Sophia
Managing insomnia and jet lag for frequent travelers
Improved sleep quality through interactive CBT-I techniques
Wendy
Managing sleep issues related to anxiety
Restored sense of self and improved sleep
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Limbix
Recent articles published on Limbix's official website.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Mental Health & Digital Therapeutics
Companies providing AI-powered mental health support, therapy platforms, mental wellness tracking, psychiatric care, digital therapeutics for mental health conditions, or AI-driven mental health screening and monitoring. Includes XR-based therapy, AI mental health screening infrastructure, and platforms supporting behavioral health for individuals and health systems.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.